Trial Profile
A study evaluating pharmacokinetics of single oral dose of NEPA in chinese healthy volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 Jul 2021
Price :
$35
*
At a glance
- Drugs Netupitant/palonosetron (Primary)
- Indications Chemotherapy-induced nausea and vomiting
- Focus Pharmacokinetics
- 10 Oct 2017 New trial record
- 12 Sep 2017 Results presented at the 42nd European Society for Medical Oncology Congress